PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 142 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,019 | -39.6% | 2,639 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $72,889 | +154983.0% | 2,639 | +28.8% | 0.00% | – |
| Q1 2023 | $47 | +113.6% | 2,049 | 0.0% | 0.00% | – |
| Q4 2022 | $22 | -99.9% | 2,049 | +2.4% | 0.00% | – |
| Q3 2022 | $16,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q2 2022 | $16,000 | -97.4% | 2,000 | -92.4% | 0.00% | -100.0% |
| Q1 2022 | $625,000 | -21.4% | 26,390 | -2.8% | 0.00% | -33.3% |
| Q4 2021 | $795,000 | +9837.5% | 27,150 | +5933.3% | 0.01% | – |
| Q3 2021 | $8,000 | -60.0% | 450 | 0.0% | 0.00% | – |
| Q2 2021 | $20,000 | +66.7% | 450 | 0.0% | 0.00% | – |
| Q1 2021 | $12,000 | +33.3% | 450 | 0.0% | 0.00% | – |
| Q4 2020 | $9,000 | – | 450 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $56,331,209 | 18.32% |
| Kynam Capital Management, LP | 1,375,000 | $31,625,000 | 4.08% |
| BVF INC/IL | 3,775,900 | $86,845,700 | 3.18% |
| Cormorant Asset Management, LP | 1,700,000 | $39,100 | 2.58% |
| RTW INVESTMENTS, LP | 4,600,799 | $105,818,377 | 2.20% |
| Ghost Tree Capital, LLC | 225,000 | $5,175,000 | 1.53% |
| 683 Capital Management, LLC | 791,000 | $18,193,000 | 1.36% |
| Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
| Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 105,486 | $2,426,178 | 1.00% |